ArticleEuropean journal of case reports in internal medicine2025
Disseminated Cryptococcosis: A Diagnostic Challenge in an Immunocompromised Patient.
Article in European journal of case reports in internal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cryptococcosis is an opportunistic fungal infection that causes disseminated disease in immunocompromised patients. Peritoneal involvement is rare and diagnostically challenging. Case report: A 76-year-old man with Crohn's disease on infliximab and previously treated latent tuberculosis was admitted with constitutional symptoms and abdominal distention evolving over 5 months. Ultrasound revealed bilateral pleural effusion and ascites. Initial hypotheses-peritoneal carcinomatosis and tuberculosis-were excluded through computed tomography scan, laboratory tests, and exploratory laparoscopy with biopsy, which showed necrotizing granulomatous peritonitis. Disseminated cryptococcosis was confirmed by India ink staining, cultures from peritoneal and pleural fluids, and serum cryptococcal antigen. Cerebrospinal fluid analysis and ophthalmological evaluation excluded central nervous system and ocular involvement. Treatment with liposomal amphotericin B and flucytosine led to clinical improvement. Conclusion: This case highlights the importance of considering cryptococcosis in the differential diagnosis of polyserositis in immunocompromised patients. Early diagnosis and antifungal therapy improve outcomes. LEARNING POINTS: Disseminated cryptococcosis, although rare, should be considered in the differential diagnosis of polyserositis and necrotizing granulomatous peritonitis in immunocompromised patients.Cryptococcus can closely mimic tuberculosis or peritoneal carcinomatosis; negative mycobacterial studies should prompt fungal investigations, including cryptococcal antigen testing.Early diagnosis and timely initiation of antifungal therapy are crucial to reduce morbidity and mortality, with treatment tailored to comorbidities such as renal dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.